Welcome to our dedicated page for Thorne Healthtech news (Ticker: THRN), a resource for investors and traders seeking the latest updates and insights on Thorne Healthtech stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Thorne Healthtech's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Thorne Healthtech's position in the market.
Thorne HealthTech (NASDAQ: THRN) has successfully closed its initial public offering, issuing 7,000,000 shares of common stock at $10.00 each, generating total gross proceeds of $70.0 million. The shares began trading on the Nasdaq Global Select Market on September 23, 2021. BofA Securities, Cowen, and Evercore ISI served as lead book-running managers for the offering. This offering aims to enhance Thorne HealthTech's position in developing innovative health solutions.
Thorne HealthTech has announced the pricing of its initial public offering (IPO) of 7,000,000 shares at $10.00 each, aiming for gross proceeds of approximately $70 million. The shares will trade on the Nasdaq under the ticker symbol THRN, starting September 23, 2021, with the offering expected to close on September 27, 2021, pending customary conditions. The underwriters have a 30-day option for an additional 1,050,000 shares. This IPO reflects Thorne HealthTech's position as a leader in personalized health solutions.